i've been thinking about this. LCT in their AGM press said that...

i've been thinking about this. LCT in their AGM press said that the Phase 3 trial would cost $10m. In the grand scheme of things that is not much money at all. If they had any sort of concept of showing off the potential of what NTCell could do they could no doubt source a JV or increase the share price to a reasonable value to therefore raise capital to undertake the Phase 3 trial. And @Zwartkops your comment that the obesity and migraine are part of the deal doesn't sound too far fetched, because it appeared that these two seemed to just come out of nothing and are all of a sudden going to yield an exit for shareholders in a very short space of time. peculiar...
I'll say it again - $10m is not much at all, not for a bigger company to invest and then yield 50% of the potential successes (in the billions) in a JV scenario
call me mad, just my thoughts
cheers